The Technical AnalystExchange: XETRA Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
HAEMATO AG Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% €21.40
Europe/Berlin / 29 feb 2024 @ 17:36
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 111.50 mill |
| EPS: | 1.850 |
| P/E: | 11.57 |
| Earnings Date: | May 02, 2024 |
| SharesOutstanding: | 5.21 mill |
| Avg Daily Volume: | 0.0041 mill |
| RATING 2024-02-29 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Sell | |
| P/E: | Strong Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/21 | 1/22 | 2/22 | 3/22 | 4/22 | 2/23 | |
| Revenue | n/a | n/a | n/a | n/a | ||
| Gr.Profit | n/a | n/a | n/a | n/a | ||
| Ebit | n/a | n/a | n/a | n/a | ||
| Asset | n/a | n/a | n/a | n/a | ||
| Debt | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.59x |
| Company: PE 11.57 | sector: PE 19.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.30x |
| Company: PE 11.57 | industry: PE 39.15 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
€ 20.69 - 21.71 ( +/- 2.41%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | €21.40 (0.00% ) |
| Volume | 0.0018 mill |
| Avg. Vol. | 0.0041 mill |
| % of Avg. Vol | 43.65 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For HAEK.DE
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
HAEK.DE
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic medicine, as well as cosmetic products. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, and medical laboratories. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.